Carregant...
Moving Beyond JUPITER: Will Inhibiting Inflammation Reduce Vascular Event Rates?
The recent JUPITER trial demonstrated that potent statin therapy reduces by 50 percent the risk of heart attack and stroke among men and women with low levels of LDL-cholesterol who are at increased vascular risk due to elevated levels of CRP, a biomarker of low-grade systemic inflammation. In JUPIT...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3817490/ https://ncbi.nlm.nih.gov/pubmed/23225175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11883-012-0295-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|